Summary & Key Points
"From September 5 to 8, 2022, the closing of the FISSA ALERRT study at the CHU Treichville was held in the Pr Marguerite TIMITE room of the PAC-CI program."
From September 5 to 8, 2022, the closing ceremony of the FISSA ALERRT study at the CHU Treichville took place in the Pr Marguerite TIMITE room of the PAC-CI program. This event was attended by the investigators, the Site Supervisor, the International and Regional Coordination of the said study. It marked the end of the site's participation in the study. The CHU Treichville site was opened on December 26, 2019, in the Adult Medical Emergencies and Pediatric Emergencies departments, with Pr Aristophane TANON as the Principal Investigator and Dr Raoul MOH as the Supervisor. The secondary investigators, assisted in their tasks by Clinical Trial Technician Patrick KOABENAN, had recruited 668 eligible adult and child participants by the end of the inclusion period on December 31, 2021. The closing was conducted by Dr Gérard MENAN, International Project Manager, and Suzanne KOUADIO, Regional Clinical Research Officer, with the support of Antoine KOUAME, Monitoring Pool Manager. As a reminder, the FISSA study was an observational study aimed at describing the epidemiology, clinical aspects, and management of febrile diseases in sub-Saharan Africa. It was conducted across fifteen (15) sites in eleven (11) countries.
